Cycling in Parkinson's Disease

October 19, 2020 updated by: Christina Marciniak, Shirley Ryan AbilityLab

A Forced Cycling Exercise Program in Individuals With Parkinson's Disease: Can it Improve Gait Parameters?

The purpose of this study is to assess the effectiveness of a forced exercise aerobic exercise program, utilizing a cycling activity, on specific gait parameters and balance in individuals with Parkinson's Disease (PD). Design: pilot, feasibility, randomized control, evaluator blinded. Subjects: Twenty four patients with idiopathic PD Hoehn and Yahr (H&Y) stage II or III. Intervention: Participants randomly assigned to one of two exercise groups, forced exercise or self selected exercise, on cycling machine three times a week for 8 weeks. Both groups to exercise at same aerobic intensity level to keep heart rate at 60-80% heart rate max. Outcomes: Gait parameters of step length, width, and variability as measured by the GAITRite; 6 Minute Walk Test; mini-BESTest (balance testing); exercise tolerance via Patient Reported Outcomes Measurement Information System (PROMIS) scale.

Study Overview

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Shirley Ryan AbilityLab (formerly the Rehabilitation Institute of Chicago)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Idiopathic Parkinson's Disease
  • Hoehn and Yahr Stages II - III.
  • Ages 30-80 years
  • Medical Clearance
  • Ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria:

  • MOCA: (Montreal Cognition Scale) : rating of less than 24, indicative of cognitive dysfunction
  • Changes in Parkinson's medications within the two weeks prior to starting the study
  • Anticipated change in Parkinson Disease medications during the course of the study
  • Uncontrolled orthostasis
  • Symptomatic coronary artery disease
  • Fracture of lower limb within 6 months prior to study onset or significant lower limb orthopedic diagnosis that would limit cycling
  • Other significant neurologic diagnoses including multiple sclerosis or vestibular disease
  • Acute illness
  • Physical therapy within the month prior to study entry
  • Subjects already participating in a forced exercise or high intensity exercise program
  • Any medical condition that the physician investigator determined would compromise safety.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Forced exercise cycling
Cycling exercise at approximately 90 rpm
Active Comparator: Self-selected pace cycling
Cycling at self selected rate, with same aerobic level as forced cycling group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6-minute walk test
Time Frame: 8 weeks
Distance walked in 6 minutes
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stride length
Time Frame: 8 weeks
Length of stride in meters as measured by the GAITrite
8 weeks
Step Width
Time Frame: 8 weeks
Width of step in meters as measured by the GAITrite
8 weeks
Step variability
Time Frame: 8 weeks
Standard deviation of step as measure in meters by the Gaitrite system
8 weeks
10 meter walk test
Time Frame: 8 weeks
Time in seconds for the subject to walk 10 meters
8 weeks
miniBESTest (Balance Evaluation Systems Test)
Time Frame: 8 weeks
Subject is scored as the 14 activities on this scale are performed, and a summary score is derived.
8 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Steps per day
Time Frame: Over 8 week trial and for 2 months post intervention
Subjects steps per day will be measured with a Garmin wrist step counter
Over 8 week trial and for 2 months post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christina M Marciniak, MD, Shirley Ryan AbilityLab/Northwestern University Chicago IL

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Sung P, Rafferty M, Doyle L, Kliver E, Bines K, Traines J, Scarpa A, Marciniak C, Solanki S, Todd A. Technology-based Forced Paced Cycling in Parkinson's disease: Is it Feasible and Effective?Archives of PM&R October 2019Volume 100, Issue 10, Page e126

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2014

Primary Completion (Actual)

June 1, 2019

Study Completion (Actual)

June 1, 2019

Study Registration Dates

First Submitted

June 21, 2014

First Submitted That Met QC Criteria

June 24, 2014

First Posted (Estimate)

June 26, 2014

Study Record Updates

Last Update Posted (Actual)

October 22, 2020

Last Update Submitted That Met QC Criteria

October 19, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson's Disease

Clinical Trials on Cycling at Forced rate

Subscribe